Cost Effectiveness Analysis Evaluating Factor Viii As Primary Prophylaxis Treatment for Patients With Severe Haemophilia A In the Netherlands

M. Kip; M. van den Bosch; K. Fischer; R. Tamminga; I Lepage-Nefkens

doi:10.1016/j.jval.2014.08.1687

Cost Effectiveness Analysis Evaluating Factor Viii As Primary Prophylaxis Treatment for Patients With Severe Haemophilia A In the Netherlands

M. Kip, M. van den Bosch, K. Fischer, R. Tamminga, I Lepage-Nefkens

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	A531-A531
Number of pages	1
Journal	Value in Health
Volume	17
Issue number	7
DOIs	https://doi.org/10.1016/j.jval.2014.08.1687
Publication status	Published - Nov-2014

Access to Document

10.1016/j.jval.2014.08.1687

Handle.net

Persistent link

Cite this

@article{de69a063e1c04fb78afe2b6aaa06a244,

title = "Cost Effectiveness Analysis Evaluating Factor Viii As Primary Prophylaxis Treatment for Patients With Severe Haemophilia A In the Netherlands",

author = "M. Kip and {van den Bosch}, M. and K. Fischer and R. Tamminga and I Lepage-Nefkens",

year = "2014",

month = nov,

doi = "10.1016/j.jval.2014.08.1687",

language = "English",

volume = "17",

pages = "A531--A531",

journal = "Value in Health",

issn = "1098-3015",

publisher = "ELSEVIER SCIENCE INC",

number = "7",

}

TY - JOUR

T1 - Cost Effectiveness Analysis Evaluating Factor Viii As Primary Prophylaxis Treatment for Patients With Severe Haemophilia A In the Netherlands

AU - Kip, M.

AU - van den Bosch, M.

AU - Fischer, K.

AU - Tamminga, R.

AU - Lepage-Nefkens, I

PY - 2014/11

Y1 - 2014/11

U2 - 10.1016/j.jval.2014.08.1687

DO - 10.1016/j.jval.2014.08.1687

M3 - Meeting Abstract

SN - 1098-3015

VL - 17

SP - A531-A531

JO - Value in Health

JF - Value in Health

IS - 7

ER -